drug

INBRX-109

1 story · latest Aug 13, 2026

Status: Investigational
Trials: 2 registered trials in coverage

Relationships

Developed by Inhibrx Biosciences, Inc

Timeline

Inhibrx reports Q2 2026 results, sets Q3 PFS readout for INBRX-106

Aug 13Quarterly updateInhibrx Biosciences, Inc

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.